Actualización de las recomendaciones de medidas de prevención y aislamiento frente al SARS-CoV-2 en las unidades de diálisis: un posicionamiento de la Sociedad Española de Nefrología

Ministerio de Sanidad. Estrategia de detección precoz, vigilancia y control de COVID-19. [Internet]. Actualización 22 de diciembre de 2021 [consultado 30 Jul 2022]. Disponible en: https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Estrategia_vigilancia_y_control_e_indicadores.pdfhttps://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/situacionActual.htm Quiroga, 2022, the Spanish COVID-19 KRT Registry collaborative group, Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: The Spanish COVID-19 KRT Registry, Clin Kidney J, 10.1093/ckj/sfac135 Vergara, 2021, The impact of age on mortality in chronic haemodialysis population with COVID-19, J Clin Med., 10, 3022, 10.3390/jcm10143022 Goicoechea, 2020, COVID-19: Clinical course and outcomes of 36 hemodialysis patients in Spain, Kidney Int., 98, 27, 10.1016/j.kint.2020.04.031 De Sequera Ortiz, 2020, Protocol against coronavirus diseases in patients on renal replacement therapy: Dialysis and kidney transplant, Nefrologia (Engl Ed)., 40, 253, 10.1016/j.nefroe.2020.03.010 Sociedad Española de Nefrología. Recomendaciones para el manejo, prevención y control de COVID-19 en Unidades de Diálisis. Sociedad Española de Nefrología, versión de 25 de marzo de 2020. Disponible en: https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19-hemodialisis.pdf Tenforde, 2021, Influenza and other viruses in the Acutely Ill (IVY) Network. Association between mRNA vaccination and COVID-19 hospitalization and disease severity, JAMA., 326, 2043, 10.1001/jama.2021.19499 Sánchez-Álvarez, 2021, Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines, Nefrologia (Engl Ed)., 41, 412, 10.1016/j.nefroe.2021.09.001 Quiroga, 2021, Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: The SENCOVAC study, Nephrol Dial Transplant. Quiroga, 2022, Humoral RESPONSE TO THIRD DOSE of SARS-CoV-2 vaccines in the CKD spectrum, Clin J Am Soc Nephrol., 17, 872, 10.2215/CJN.01770222 El Karoui, 2022, COVID-19 in dialysis: Clinical impact, immune response, prevention, and treatment, Kidney Int., 101, 883, 10.1016/j.kint.2022.01.022 Quiroga, 2022, SARS-CoV-2 infection evolution among nephrologists during the pandemic: Clinical features and impact of vaccination, Kidney Int Rep., 7, 1686, 10.1016/j.ekir.2022.04.093 Sánchez-Álvarez, 2021, Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines, Nefrologia (Engl Ed)., 41, 412, 10.1016/j.nefroe.2021.09.001 CDC. How to talk to your close contacts: how to do if you have COVID-19. Centers for Disease Control and Prevention. 2019. Disponible en: cdc.gov/coronavirus. Al Bayat, 2021, Can the cycle threshold (Ct) value of RT-PCR test for SARS CoV2 predict infectivity among close contacts?, J Infect Public Health, 14, 1201, 10.1016/j.jiph.2021.08.013 Bullard, 2020, Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples, Clin Infect Dis, 71, 2663, 10.1093/cid/ciaa638 GTM. Actualización del informe del GTM sobre pruebas de diagnóstico de COVID-19. Grupo de Trabajo Multidisciplinar. Disponible en: https://www.ciencia.gob.es/dam/jcr:18bca105-e674-4f7b-858d-2d78b39ffa04/Actualizacion_pruebas_diagnostico.pdf Jefferson, 2021, Viral cultures for coronavirus disease 2019 infectivity assessment: A systematic review, Clin Infect Dis., 73, e3884, 10.1093/cid/ciaa1764 Meo, 2021, Omicron SARS-CoV-2 new variant: Global prevalence and biological and clinical characteristics, Eur Rev Med Pharmacol Sci., 25, 8012 Shang, 2022, Percentage of asymptomatic infections among SARS-CoV-2 omicron variant-positive individuals: A systematic review and meta-analysis, Vaccines (Basel)., 10, 1049, 10.3390/vaccines10071049 Estrategia de detección precoz, vigilancia y control de COVID-19. Centro de Coordinación de Alertas y Emergencias Sanitarias. Ministerio de Sanidad. Actualizado 12 de agosto de 2021 [consultado 30 Jul 2022]. Disponible en: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Estrategia_vigilancia_y_control_e_indicadores.pdf. European Centre for Disease Prevention and Control. Guidance for discharge and ending isolation of people with COVID-19. 16 Oct 2020. Estocolmo: ECDC; 2020. CDC. Guidelines for Environmental Infection Control in Health-Care Facilities. 2003. Disponible en: https://www.cdc.gov/infectioncontrol/guidelines/environmental/appendix/air.html Estrategia de Vigilancia y Control frente a COVID-19 tras la fase aguda de la pandemia; actualización 3 de junio de 2022. Disponible en: https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Nueva_estrategia_vigilancia_y_control.pdf